⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNY News
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
Das Gesundheitsministerium und Sanofi gehen Partnerschaft ein, um Innovationen im Bereich der Impfstoffe voranzutreiben
prnewswire.com
SNY
Questex’s PODD, the Premier Gathering for Drug Delivery Industry Leaders, Announces the 16th Annual Conference Agenda
globenewswire.com
ABBV
ALNY
ASTL
AZN
BIIB
BMY
CSL
LLY
GILD
GSK
MRK
NVS
NVO
PFE
REGN
SNY
SUN
TEVA
UPST
VRTX
Press Release: Sanofi’s Wayrilz approved in Japan to treat immune thrombocytopenia
globenewswire.com
SNY
Press Release: Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses
globenewswire.com
SNY
DoH and Sanofi Partner to Advance Vaccine Innovation
prnewswire.com
SNY
DoH and Sanofi Partner to Advance Vaccine Innovation
prnewswire.com
SNY
Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
globenewswire.com
QNTM
SNY
BIIB
CLNN
Raymond Rodriguez-Torres Appointed First Ascent Biomedical New President to Scale Functional Precision Oncology
prnewswire.com
SNY
TrueLab Biopharmaceutical gibt Lizenzvereinbarung mit Bionyra Pharma über zwei monoklonale und bispezifische Antikörper der nächsten Generation zur Behandlung immunvermittelter Entzündungskrankheiten im Wert von bis zu 985 Millionen US-Dollar bekannt
prnewswire.com
SNY
TrueLab Biopharmaceutical Announces License Agreement with Bionyra Pharma for Two Next-Generation Monoclonal and Bispecific Antibodies for Immune-Mediated Inflammatory Diseases Valued up to $985 Million
prnewswire.com
SNY